Kumar, R., Prem, S., Mahapatra, M., Seth, T., Chowdhary, D., Mishra, P., … Choudhry, V. (2006). Fludarabine, cyclophosphamide and horse antithymocyte globulin conditioning regimen for allogeneic peripheral blood stem cell transplantation performed in non-HEPA filter rooms for multiply transfused patients with severe aplastic anemia. Bone Marrow Transplantation, 37(8), 745-9. https://doi.org/10.1038/sj.bmt.1705321

Pillai, L., Sha, J., Erova, T., Fadl, A., Khajanchi, B., & Chopra, A. (2006). Molecular and functional characterization of a ToxR-regulated lipoprotein from a clinical isolate of Aeromonas hydrophila. Infection and Immunity, 74(7), 3742-55. https://doi.org/10.1128/IAI.00402-06

Pillai, L., Chouvarine, P., Tudor, C., Schmidt, C., Vijay-Shanker, K., & McCarthy, F. Developing a biocuration workflow for AgBase, a non-model organism database. Database : The Journal of Biological Databases and Curation, 2012, bas038. https://doi.org/10.1093/database/bas038 (Original work published 2012)

Srinivas, U., Pillai, L., Kar, R., Mahapatra, M., Gujra, S., & Pati, H. (2007). A case of rhabdomyosarcoma masquerading as acute leukemia at presentation: a case report. Indian Journal of Pathology & Microbiology, 50(4), 917-9.

Yanow, J., Pappagallo, M., & Pillai, L. (2008). Complex regional pain syndrome (CRPS/RSD) and neuropathic pain: role of intravenous bisphosphonates as analgesics. TheScientificWorldJournal, 8, 229-36. https://doi.org/10.1100/tsw.2008.33 (Original work published 2008)

Kumar, N., Hinduja, I., Nagvenkar, P., Pillai, L., Zaveri, K., Mukadam, L., … Bhartiya, D. (2009). Derivation and characterization of two genetically unique human embryonic stem cell lines on in-house-derived human feeders. Stem Cells and Development, 18(3), 435-45. https://doi.org/10.1089/scd.2008.0234

Zimmerman, P., d’Audiffret, A., & Pillai, L. (1969). Endovascular repair of blunt extremity arterial injury: case report. Vascular and Endovascular Surgery, 43(2), 211-4. https://doi.org/10.1177/1538574408326181 (Original work published 1969)

Pillai, L., Burnett, B., Levy, R., & Cooperative, G. G. S. (2010). GOAL: multicenter, open-label, post-marketing study of flavocoxid, a novel dual pathway inhibitor anti-inflammatory agent of botanical origin. Current Medical Research and Opinion, 26(5), 1055-63. https://doi.org/10.1185/03007991003694522

Pillai, L., Levy, R., Yimam, M., Zhao, Y., Jia, Q., & Burnett, B. (2010). Flavocoxid, an anti-inflammatory agent of botanical origin, does not affect coagulation or interact with anticoagulation therapies. Advances in Therapy, 27(6), 400-11. https://doi.org/10.1007/s12325-010-0040-7

Levy, R., Khokhlov, A., Kopenkin, S., Bart, B., Ermolova, T., Kantemirova, R., … Burnett, B. (2010). Efficacy and safety of flavocoxid, a novel therapeutic, compared with naproxen: a randomized multicenter controlled trial in subjects with osteoarthritis of the knee. Advances in Therapy, 27(10), 731-42. https://doi.org/10.1007/s12325-010-0064-z